Yahoo Finance18 天
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
MALVERN, Pa., Dec. 9, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI) announced today that the U.S. Food and Drug Administration (FDA) has approved commercial production of VASOSTRICT ® (vasopressin injection, ...
Finanznachrichten3 个月
Endo, Inc.: Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
India. The 20,000-square-foot site increases Endo's sterile injectable production capacity and expands the future growth potential for its Injectable Solutions business. "This is a significant ...
Nasdaq18 天
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
MALVERN, Pa., Dec. 9, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that the U.S. Food and Drug Administration (FDA) has approved commercial production of VASOSTRICT® (vasopressin ...